Seroprevalence of IgG antibodies against measles in health care workers of the Strakonice Hospital

Česká verzia

Authors: J. Fleischmannová; E. Šimečková
Authors place of work: Nemocnice Strakonice, a. s.
Published in the journal: Epidemiol. Mikrobiol. Imunol. 69, 2020, č. 3, s. 121-126
Category: Původní práce

Summary

Aim: Due to mandatory vaccination introduced in the Czech Republic since 1969, only few measles cases were reported annually until recently. However, a rapid increase of cases has been recorded in last two years. In contrast to the pre-vaccination era, in recent measles outbreaks, many cases have been reported among vaccinated adults. Health care workers (HCWs) are particularly at high risk of contact with measles. Therefore, to minimize transmission in health care settings, many hospitals evaluate measles immune status of their HCWs and offer free vaccination to those with too low anti-measles antibody levels. The aim of this study was to evaluate the seroprevalence of IgG antibodies against measles in all HCWs of the Strakonice Hospital.

Materials and Methods: Anti-measles IgG serum levels were measured using quantitative ELISA.

Results: Almost all HCWs born before 1969, when the mandatory vaccination started, showed high levels of IgG antibodies (93.5%). Contrarily, among previously vaccinated individuals, only 64.8% were seropositive. A high percentage of seronegative or borderline samples was observed even in the age groups who were previously vaccinated with two doses.

Conclusions: In total, 25.4% of all HCWs of the Strakonice Hospital had too low anti-measles IgG levels, and most of them were immunized with one dose of MMR vaccine. Prioritized vaccination substantially decreased the number of staff at higher risk of measles acquisition and, at the same time, of those who would need to be quarantined after exposure.

Keywords:

measles – immunization – waning immunity – health care workers

Zdroje

1. Leung AK, Hon KL, Leong KF, et al. Measles: a disease often forgotten but not gone. Hong Kong Med J, 2018;24(5):512–520.

2. Ministerstvo zdravotnictví ČR. Rizika onemocnění spalničkami a možnosti prevence [on line]. 2019-04-15 [cit. 2019-11-12]. Dostupné na www: <http://www.mzcr.cz/verejne/dokumenty/rizika-onemocneni-spalnickami-a-moznosti-prevence_17081_4011_5.html>.

3. World Health Organization. Measles in Europe: Record number of both sick and immunized [on line]. 2019-02-07 [cit. 2019-10-21]. Dostupné na www: <http://www.euro.who.int/en/media-centre/sections/press-releases/2019/measles-in-europe-record-number-of-both-sick-and-immunized>.

4. World Health Organization. WHO EpiData: A monthly summary of the epidemiological data on selected vaccine-preventable diseases in the WHO European Region [on line]. 2020-02-07 [cit. 2020-05-21]. Dostupné na www: <http://www.euro.who.int/__data/assets/pdf_file/0007/427930/2020-01-Epi_Data_EN_January-December-2019.pdf?ua=1>.

5. Státní zdravotní ústav. Výskyt vybraných hlášených infekcí v České republice, leden – prosinec 2019 porovnání se stejným obdobím v letech 2010–2018 (počet případů) [on line]. 2020-01-02 [cit. 2020-05-21]. Dostupné na www: http://www.szu.cz/uploads/documents/szu/infekce/tabulka_leden_prosinec_2019.pdf

6. World Health Organization. European region loses ground in effort to eliminate measles [on line]. 2019-08-29 [cit. 2019-10-21]. Dostupné na www: <http://www.euro.who.int/en/media-centre/sections/press-releases/2019/european-region-loses-ground-in-effort-to-eliminate-measles>.

7. Steingart RK, Thomas RA, Dykewicz AC, et al. Transmission of measles virus in healthcare settings during a community wide outbreak. Infect Control Hosp Epidemiol, 1999;20:115–119.

8. Bílková Fránková H, Kloudová A, Zelená H, et al. Víceúčelový sérologický přehled (spalničky, příušnice, pertuse, virová hepatitida B) SP 2013, ČR: Závěrečná zpráva, příloha č.1. Zprávy CEM (SZÚ, Praha) 2014; 23:1–152. ISSN 1804-8668. Dostupné také na www: <http://www.zuusti.cz/wp-content/uploads/2015/04/SP-2013-vnitřek-do-TISKU.pdf>.

9. Smetana J, Chlibek R, Hanovcova I, et al. Decreasing Seroprevalence of Measles Antibodies after Vaccination – Possible Gap in Measles Protection in Adults in the Czech Republic. PLoS One, 2017;12(1):e0170257.

10. Slonim D. Stručný pracovní životopis. 4. vydání, Praha, 2014.

11. Vyhláška č. 355 ze dne 17. října 2017, kterou se mění vyhláška č. 537/2006 Sb., o očkování proti infekčním nemocem, ve znění pozdějších předpisů. In: Sbírka zákonů České republiky. 2017, částka 123/2017:3898–3904. Dostupné na www: <file:///C:/Users/Simeckova/Downloads/sb0123-2017.pdf >.

12. Davidkin I, Jokinen S, Broman M, et al. Persistence of measles,mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis, 2008;197(7):950–956.

13. Watson JC, Pearson JA, Markowitz LE, et al. An evaluation of measles revaccination among school-entry-aged children. Pediatrics, 1996;97(5):613–618.

14. Fabiánová K, Manďáková Z, Lexová P, et al. Souhrn aktuálních poznatků v prevenci onemocnění spalničkami; doporučení Advisory Committee on Immunization Practices (ACIP) v kontextu současné epidemiologické situace v ČR. Zprávy CEM (SZÚ, Praha), 2018; 27(5):110–112. Dostupné na www: <http://www.szu.cz/uploads/Epidemiologie/Spalnicky/Spalnicky_clanek_Zpravy_CEM_SZU_2018.pdf >.

15. Bitzegeio J, Majowicz S, Matysiak-Klose D, et al. Estimating age-specific vaccine effectiveness using data from a large measles outbreak in Berlin, Germany, 2014/15: evidence for waning immunity. Euro Surveill, 2019;24(17):pii=1800529. Dostupné na www: <https://doi.org/10.2807/1560-7917.ES.2019.24.17.1800529>.

16. Augusto GF, Cruz D, Silva A, et al. Challenging measles case definition: three measles outbreaks in three Health Regions of Portugal, February to April 2018. Euro Surveill, 2018;23(28):pii=180032. Dostupné na www: <https://doi. org/10.2807/1560-7917.ES.2018.23.28.1800328>.

17. Sá Machado R, Perez Duque M, Almeida S, et al. Measles outbreak in a tertiary level hospital, Porto, Portugal, 2018: challenges in the post-elimination era. Euro Surveill, 2018;23(20):pii=18-00224. Dostupné na www: <https://doi.org/10.2807/1560-7917. ES.2018.23.20.18-00224>.

18. Sundell N, Dotevall L, Sansone M, et al. Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections. Euro Surveill, 2019;24(17):pii=1900114. Dostupné na www: <https://doi.org/10.2807/1560-7917.ES.2019.24.17.1900114>.

19. Rosen JB, Rota JS, Hickman CJ, et al. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011. Clin Infect Dis, 2014;58(9):1205–1210.

20. Avramovich E, Indenbaum V, Haber M, et al. Measles Outbreak in a Highly Vaccinated Population – Israel, July–August 2017. MMWR Morb Mortal Wkly Rep, 2018;67:1186–1188.

21. Vyhláška ze dne 17. prosince 2008, o systému epidemiologické bdělosti pro vybrané infekce, ve znění pozdějších předpisů. In: Sbírka zákonů České republiky, 2008, částka 151/2008:8010–8043. Dostupné na www: <https://www.infekce.cz/Legislativa/vyhl-473-2008.pdf >.

22. Maltezou HC, Poland GA. Immunization of Health-Care Providers: Necessity and Public Health Policies. Healthcare (Basel), 2016;4(3). pii: E47. Dostupné na www: <https://doi.org/10.3390/healthcare4030047>.

23. Centre for Disease Prevention and Control. Routine Measles, Mumps, and Rubella Vaccination [on line]. 2019-06-12 [cit. 2020-02-17]. Dostupné na www: <https://www.cdc.gov/vaccines/vpd/mmr/hcp/recommendations.html>.

24. Ministerstvo zdravotnictví ČR. Opatření ministra zdravotnictví ke zvýšení proočkovanosti proti spalničkám u zdravotnických pracovníků [on line]. 2019-02-22 [cit. 2019-11-08]. Dostupné na www: <http://www.mzcr.cz/dokumenty/opatreni-ministra-zdravotnictvi-ke-zvyseni-proockovanosti-proti-spalnickam-u-zdr_16851_3970_1.html>.

25. LeBaron CW, Beeler J, Sullivan BJ, et al. Persistence of measles antibodies after 2 doses of measles vaccine in a postelimination environment. Arch Pediatr Adolesc Med, 2007;161(3):294–301.